- Home
- BOLT vs IRIX Comparison
BOLT vs IRIX Comparison
Compare BOLT & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- IRIX
- Stock Information
- Founded
- BOLT 2015
- IRIX 1989
- Country
- BOLT United States
- IRIX United States
- Employees
- BOLT N/A
- IRIX N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BOLT Health Care
- IRIX Health Care
- Exchange
- BOLT Nasdaq
- IRIX Nasdaq
- Market Cap
- BOLT 25.3M
- IRIX 28.6M
- IPO Year
- BOLT 2021
- IRIX 1996
- Fundamental
- Price
- BOLT $0.52
- IRIX $1.69
- Analyst Decision
- BOLT Hold
- IRIX Hold
- Analyst Count
- BOLT 5
- IRIX 1
- Target Price
- BOLT $1.25
- IRIX $2.00
- AVG Volume (30 Days)
- BOLT 168.8K
- IRIX 20.6K
- Earning Date
- BOLT 11-12-2024
- IRIX 11-12-2024
- Dividend Yield
- BOLT N/A
- IRIX N/A
- EPS Growth
- BOLT N/A
- IRIX N/A
- EPS
- BOLT N/A
- IRIX N/A
- Revenue
- BOLT $9,779,000.00
- IRIX $48,431,000.00
- Revenue This Year
- BOLT $9.87
- IRIX N/A
- Revenue Next Year
- BOLT N/A
- IRIX $5.44
- P/E Ratio
- BOLT N/A
- IRIX N/A
- Revenue Growth
- BOLT 35.86
- IRIX N/A
- 52 Week Low
- BOLT $0.50
- IRIX $1.27
- 52 Week High
- BOLT $1.56
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- BOLT 38.20
- IRIX 50.88
- Support Level
- BOLT $0.50
- IRIX $1.61
- Resistance Level
- BOLT $0.59
- IRIX $1.82
- Average True Range (ATR)
- BOLT 0.03
- IRIX 0.08
- MACD
- BOLT -0.00
- IRIX -0.02
- Stochastic Oscillator
- BOLT 24.49
- IRIX 35.94
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.